The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
Diagnosis and Management of a Hypersensitivity Reaction to Titanium-Containing Surgical Clips: A Case Report
Cureus
13 Feb 2023
https://pubmed.ncbi.nlm.nih.gov/36938272/
Yusuf (YP) Saleeby, MD - Update on COVID, Long COVID and LDN (LDN; low dose naltrexone)
Repurposed drugs are cheap (News)
Dr. John Campbell
09 February 2023
https://www.youtube.com/watch?v=Iw7Xz-wl5Lo
Repurposed drugs are common in medicine, aspirin, morphine, viagra and prednisolone for example. After drugs have been on the market for about 15 years, their patent runs out and they can be mass produced as a very inexpensive ‘generic’ drug.
LDN therapy hope for the desired pregnancy? (in Polish) (News)
Medexpress.pl
05 February 2023
https://www.medexpress.pl/terapia-ldn-nadzieja-na-upragniona-ciaze/86337
Kristen Burris LAc, MSTOM - Acupuncture and Chinese Herbal Medicine(LDN; low dose naltrexone)
Oral Low-Dose Naltrexone in the Treatment of Frontal Fibrosing Alopecia and Lichen Planopilaris...
Cureus
24 January 2023
https://www.cureus.com/articles/132544-oral-low-dose-naltrexone-in-the-treatment-of-frontal-fibrosing-alopecia-and-lichen-planopilaris-an-uncontrolled-open-label-prospective-study#!/
How Long Does it Take Low Dose Naltrexone to Work?
The Enlightened Mindset
15 January 2023
https://www.lihpao.com/how-long-does-it-take-low-dose-naltrexone-to-work/
Fourteen Percent of Those Who Contracted COVID-19 Face Long-Term Challenges
Pharmacy Times
16 January 2023
https://www.pharmacytimes.com/view/fourteen-percent-of-those-who-contracted-covid-19-face-long-term-challenges
Clinicians Discuss Major Treatments for Long COVID–The Effective and the Questionable
The Epoch Times
02 January 2023
https://www.theepochtimes.com/health/clinicians-discuss-major-treatments-for-long-covid-the-effective-and-the-questionable_4950709.html
Fibromyalgia Year in Review: 2022
Rhematologynetwork.com
26 December 2022
https://www.rheumatologynetwork.com/view/fibromyalgia-year-in-review-2022